{"name":"Lepu Biopharma Co., Ltd.","slug":"lepu-biopharma-co-ltd","ticker":"","exchange":"","domain":"lepu.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxNc2c4SkNxa2x4OXNZbjktM1VjQWlJRnZUcWp3UC03MGRoMnlvU3FlbEdyM3hxaFU0MU1OQkhXbUpQNUI3QlB2dGYwRnpCcmRXN2ZiQzZsRlVyY0ZxaFNiM2RhN08xREotbURZTU1KcjRmWDlYMnlaRV9kVE1WTWdPcEJVUy1XV01CZDYxVGJWQjJSVE1DOVZHX2hNYjNsWElZd05CcWw0bjJ1QkxNd3VNVFgzVWtwTnlwbXFBUlBLbFg1TEtlQXptRzRoaDRUeVk2Z3RTbHo1TE5YSGxYcXFPaVVGQUprU284M0JIdHpsdw?oc=5","date":"2026-01-21","type":"regulatory","source":"Citeline News & Insights","summary":"Will Chinese Firms Take More Domestically Approved FIC Drugs To The World In 2026? - Citeline News & Insights","headline":"Will Chinese Firms Take More Domestically Approved FIC Drugs To The World In 2026? - Citeline News & Insights","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxPRVdvcjFvdmVSOWJGckZzNkk0NnZNTXNZd1padTBSZ2NCQkRrMHJSZ0pCbUlWOEc5WkJUQmpkZGVGWU5kblYyM182a1Rvc3JxQ0M5UUFVTVN1RUk5T2hTemVhVU9VSFdKQm9SNXVHSVIxVlpkVm0yWnlybkxrWWxFclJtZTdCRVRjWWJvLVlzMFV0VDZ4QzFYbUJtRm1wVEJKeUROTElwS01oTEtMYVVFcVBOUTZEck8wTVdCVHhuUVNpcnZoTXRrZ0pxOXNoVEh3bHk1QjJsWGRESDlUSGNmZ1VOMmRIOUJQUVRDTDVUTDk2VTB6bUNUYVhGN0U1aWxJeFo5NjZOaWRHYUMwU2lOUzlTNmlwejFseFBkWG9QZC1NLUFmYzFxMlB2d2pKS2NmSkNCR0FmM040T2lHRHN6UHpUWTg?oc=5","date":"2025-11-21","type":"deal","source":"PR Newswire","summary":"BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Milestone in Mutual Collaboration in Biologics CMC - PR Newswire","headline":"BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Mi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNLXM5aUw4LWcxcUZJZ2RzOFRSZUtyNkEzQjNrUmY5cWRiMFJWT29JRldEZzA1Z1d1b1N2UFVWYzE1NldZbmJ1OWRmRG9KRjhlSkg4d0xnZlRXeERsUE5mUWFtMnE4YjJydGJQWXdyLXJNTlBsMlVFbV91UERNUm45T0cwUENMTEV0OFU1MmhIZjJ5VVpZSUFxcDI0dnp1SnU4Q1AwZVZXU1NldGlOOWpFUFNpd2dUSi1yNGlpMWtRNWM4NWktMWhVclVYc0JLNWxzYzNCcW1KbGhsQkVLN2JsZUFiZzRTNk8xWG1oUWZBeEpjb0tW?oc=5","date":"2025-11-05","type":"regulatory","source":"PR Newswire","summary":"BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC - PR Newswire","headline":"BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNdUVtX2dCNV9qWHV5d25NcnBsYVFKU1J4SThBTUtGZ2t6dzg4SXVLc1g4UTRKS2g4bmN2XzJaSFJlZDN2MGxYeXl4T05reUVIVkEyOE9FVEFpeTliTk1GX0xiZDJRWW9QM1pwMzd6bEV4RzE3YWItMEZ5Tk5MSDNQZw?oc=5","date":"2025-09-08","type":"deal","source":"Pharmaceutical Technology","summary":"Hengrui Pharma signs deal with Braveheart Bio for HRS-1893 - Pharmaceutical Technology","headline":"Hengrui Pharma signs deal with Braveheart Bio for HRS-1893","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPTE84OXN2YUYzdzYwNy0xbktuUWZydkQxV0VJRTNsTncwUFplUFlMNFdFMGlUeEFMTy1OQVdmc1NJdGpSU3l5TU1jZVo1WndmYXZJQnJmUW9IVm9TbDhwSWdlSVhIZVkzMzN3MTgxdlpFQzJpeHN3ODBGR3J4SnhIRkZUYnVGRDRNRE5iUGp6eWNVWkgwLVRndmRaOWhnWjJTekplRGg3MA?oc=5","date":"2025-08-05","type":"deal","source":"BioWorld News","summary":"Lepu out-licenses T-cell engagers to newco Excalipoint for $857M - BioWorld News","headline":"Lepu out-licenses T-cell engagers to newco Excalipoint for $857M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQVHI4MG5idDZaMUVwODRYVXZIcEhlbFlOaFpvQkVVaDdwNFMzYmdURWlkY3JHM01LX2dSY01HdXU3MG9wYjFtSUcyU2VGVGd6amJYc2tnQVpEd3R0dlE2aHhLMEF1ZXFYN29OVlRldzYtd25VdmtWWjE4a1RJNFZKbXpwNGU4ZGxDc0lmdmY1LWFTSkRmNi1TU05wTQ?oc=5","date":"2025-06-03","type":"pipeline","source":"BioWorld News","summary":"Astellas nabs Evopoint’s CLDN18.2-targeting ADC for $1.34B - BioWorld News","headline":"Astellas nabs Evopoint’s CLDN18.2-targeting ADC for $1.34B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5KQWRnUzNaSjNEWHpPdl9iS0lUMC1ITURZajd2X21LQ2Q5TDhxUzRXcDlQUUxqVGFRSks0RnBkVWdERTRXQkpndWFlTEhCbXBuX1Qw?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"AVBP Stock Price, News & Analysis - Stock Titan","headline":"AVBP Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5fZnpBS054a2hJRXM2TWJISkhoMERzYmlGcGFxdFIyNUZ3bDZjam9FV254QkU5WlZmZExsQ0dFN1NXaFJTeFROLTM2T0czWDhOR09KMktaZnVwTVdkamlrNTN2NTRfZEduU2s0UDNzakh5UUhodzZlb21maVlHUQ?oc=5","date":"2025-03-26","type":"pipeline","source":"Pharmaceutical Technology","summary":"MSD enters agreement with Hengrui Pharma for Lp(a) inhibitor - Pharmaceutical Technology","headline":"MSD enters agreement with Hengrui Pharma for Lp(a) inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNZEZWS2U4SUdrSUIzZ3FCUjV0NWFOM3o5T1NsOVR0RVFGeUlQOEtESnVHTkV6R0lXU18xanE1WUNDYlhFb1VqY09CMXh5NnJfX2p2cER3cWFuSUJQVm12SVRsaThOdnBxamtUZ1ZGamNZM3U5bkw1M2h6eFB6YmZLdFphSlU0SUtwaHJpSk9aUzU4enVTM1c5SEo3ODRZSlFkM0daX1ctUTRQWXpENXpQaTBn?oc=5","date":"2025-01-23","type":"deal","source":"BioWorld News","summary":"More China ADCs: Arrivent gets GI cancer drug in $1.2B Lepu deal - BioWorld News","headline":"More China ADCs: Arrivent gets GI cancer drug in $1.2B Lepu deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQSkZMQTEzLWhDYnAyb0hIS3NGeDVCdUtBQ0tVUFl4VkNhUWtXM1JTbk1JdXlxTFNUSUxOOWd2OTFLbnU0Yl9GcUlqbjVBMWU4QlhyTW1WX0tIcXEybTVSM3ozNVBINmE2Z210YXQ3bjRxWUVhNFp6X2FjaFdyd3ltMmg4di1HTm9LeU9XOGpsT1pCVnJGd0trcGc2SzFLYS1wNFpWQg?oc=5","date":"2025-01-21","type":"deal","source":"BioWorld News","summary":"Newco Prolium licenses antibody from Innocare, Keymed for $520M - BioWorld News","headline":"Newco Prolium licenses antibody from Innocare, Keymed for $520M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPc3EzXzNaMHJYbEpEeFI4ZndENUtrbjFpRU5XeENsOUpvbjFTRmVicm5zX2FFaUJseEtPRnBycFpiZ1hhdUVDQWFyT3ZIajhWQ2JzeEFScGx0bE9yYkpjd3k3aUpqUDRqS0FFUDJvNHNpdnBSNWIwcDIwcVVVVTFPbWV4RGg2RThPOUQyX3lkYkQ?oc=5","date":"2025-01-20","type":"pipeline","source":"San Diego Business Journal","summary":"Timberlyne Nabs $180M Series A - San Diego Business Journal","headline":"Timberlyne Nabs $180M Series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNSEd2cG5fcEIyTnV4T0szSVk0M21RYjBvY1BfT3lpM3ZYWlBhNEgtMUt6aXhzX3lUeWZHelNpUTZuZmdCUGcxQXVKakRzYmJ5Ykx1andKVUlzYWhQNTVCMXBtNzlTOS1hZmxsR25IaGotV1JwcnVZc251QURlT1VZbG9Pczk5TVA4Z1EtbkxNUXhHNGVfZG1pa2Y4X3QwVEtkLVVwQWN2aTJyU0NFVV9lWF9Pc2lIbFBNTE92YVlCNzdYM3NZ?oc=5","date":"2023-02-23","type":"deal","source":"Contract Pharma","summary":"Keymed, Lepu Biopharma Enter Global License Agreement with AstraZeneca for CMG901 - Contract Pharma","headline":"Keymed, Lepu Biopharma Enter Global License Agreement with AstraZeneca for CMG901","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}